Required information The following information 'applies to the questions displayed below] The December 31, 2018, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company's fiscal year-end Account Title Debits Credits 20,000 35,000 5, 000 50,000 100,000 Cash Accounts receivable Prepaid rent Inventory Equipment Accumulated depreciation-equipment Accounts payable Salaries and wages payable Common stock Retained earnings Sales revenue Cost of goods sold Salaries and wages expense Rent expense 30,000 25,000 100,000 29,000 323,000 180,000 71,000 30,000 Depreciation expense Utility expense Advertising expense 12,000 4,000 Totals 507,000507,866 The following year-end adjusting entries are required a. Depreciation expense for the year on the ecuipment is $10000 b. Accrued sataries and wages payable at year-end should be $4,000